ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cognitive dysfunction"

  • Abstract Number: 0417 • ACR Convergence 2023

    The Role of Rheumatoid Arthritis Flare in the Risk of Alzheimer’s Disease and Related Dementias: A Population-based Cohort Study

    Chanakya Kodishala1, Tina Gunderson2, Edward Lovering2, Rakesh Kumar2, Cynthia Crowson2, John Davis2 and Elena Myasoedova2, 1Mayo Clinic Rochester Minnesota, Rochester, MN, 2Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with rheumatoid arthritis (RA) have increased risk for Alzheimer's disease and related dementias (AD/ADRD). Recent studies have reported an association between RA disease…
  • Abstract Number: 2303 • ACR Convergence 2023

    Are Neuropsychiatric Symptoms in Systemic Lupus Erythematosus (NPSLE) Associated with More Frequent Hospitalizations or Exposure to a Greater Number of Immunosuppressive Medications?

    Jaime Vondenberg1, Chao Zhang1 and Emily Littlejohn2, 1Cleveland Clinic Foundation, Cleveland, OH, 2Cleveland Clinic, Cleveland, OH

    Background/Purpose: Neuropsychiatric (NP) symptoms occur in >50% of patients with systemic lupus erythematosus (SLE). A major barrier to research includes the non-specific nature of neuropsychiatric…
  • Abstract Number: 0549 • ACR Convergence 2023

    Development of Customized Digital Cognitive Assessment Battery: A Pilot Use Case in SLE Patients

    Priyanka Srivastava1 and Liza Rajasekhar2, 1International Institute of Information Technology, Hyderabad, India, 2Nizam's Institute of Medical Sciences, Madhapur, India

    Background/Purpose: Reported prevalence of cognitive dysfunction (CD) in SLE varies from 3%-88%1.Variability may be due to use of tools insensitive to population characteristics like literacy,…
  • Abstract Number: 2446 • ACR Convergence 2023

    Intermittent Fasting Attenuates Cognitive Dysfunction in Murine Systemic Lupus Erythematosus

    Yi Feng, Jiayu Qin, Lijuan Zheng, Hao Ren, Min Yang and Qin Huang, Department of Rheumatology, Nanfang Hospital, Southern Medical University, Guangzhou, China

    Background/Purpose: Cognitive dysfunction is one of the most common manifestations of neuropsychiatric systemic lupus erythematosus (NPSLE) and severely affects patients' health-related quality of life. Intermittent…
  • Abstract Number: 0558 • ACR Convergence 2023

    Elevated Serum Levels of S100A8/A9 Discriminate Systemic Lupus Erythematosus Patients with Cognitive Impairment from Patients Without Impairment

    Carolina Munoz-Grajales1, Michelle Barraclough2, Juan Pablo Diaz Martinez3, Jiandong Su2, Kathleen Bingham2, Mahta Kakvan4, Roberta Kretzmann5, Carmela Tartaglia6, Lesley Ruttan7, May Choi8, Simone Appenzeller9, Sherief Marzouk5, Dennisse Bonilla2, Patti Katz10, Dorcas Beaton11, Robin Green5, Joan Wither2 and Zahi Touma5, 1UHN/TWH, Toronto, ON, Canada, 2University Health Network, Toronto, ON, Canada, 3Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 4University Health Network, University of Toronto, Toronto, ON, Canada, 5University of Toronto, Toronto, ON, Canada, 6Krembil Brain Institute, University Health Network, University of Toronto, Toronto, ON, Canada, 7University Health Network, Toronto Rehabilitation Institute, Toronto, ON, Canada, 8University of Calgary, Calgary, AB, Canada, 9UNICAMP, Campinas, Brazil, 10University of California San Francisco, San Rafael, CA, 11Institute for Work & Health, Toronto, ON, Canada

    Background/Purpose: Cognitive impairment (CI) is one of the most common manifestations of Neuropsychiatric Systemic Lupus Erythematosus (NPSLE). Studies have reported that SLE patients with different…
  • Abstract Number: 2449 • ACR Convergence 2023

    Cognitive Functioning Among Individuals with Systemic Lupus Erythematosus: A Population-Based Study

    Laura Plantinga1, C. Barrett Bowling2, Charmayne Dunlop-Thomas1, Courtney Hoge1, Bradley Pearce1, Cristina Drenkard1 and S. Sam Lim1, 1Emory University, Atlanta, GA, 2Duke University, Durham, NC

    Background/Purpose: Studies of objectively measured cognitive dysfunction in SLE are often limited by small sample size, limited generalizability, and lack of diversity. We sought to…
  • Abstract Number: 1219 • ACR Convergence 2023

    Patient Experience of Brain Fog to Inform the Development of a De Novo Patient Reported Outcome (PRO) in Patients with Sjögren’s Disease

    Denise Kruzikas1, Ann Eldred2, Shelly Kafka3, Janet Church4, Katherine Hammitt4, Patricia Koochaki5 and Christina O'Donnell6, 1AbbVie, Inc., North Chicago, IL, 2AbbVie, Inc., Lake Bluff, IL, 3AbbVie, Inc., Norristown, PA, 4Sjögren’s Foundation, Reston, VA, 5ICON Clinical Research LLC, Raleigh, NC, 6ICON plc, Raleigh, NC

    Background/Purpose: Brain fog is commonly reported by SJD patients, though limited evidence exists to understand patient experiences. Various terms may be used to describe brain…
  • Abstract Number: 1226 • ACR Convergence 2023

    Examining the Relationship Between Socioenvironmental Factors and Cognitive Functioning in Youth with Childhood-Onset Systemic Lupus Erythematosus

    Ashley Danguecan1, Ibrahim Mohamed2, Sarah Mossad1, Tala El Tal3, Adrienne Davis1, Asha Jeyanathan1, Sona Sandhu1, Lawrence Ng1, Paris Moaf1, Deborah Levy1, Linda Hiraki1 and Andrea Knight1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital for Sick Children, Brampton, ON, Canada, 3Children's Hospital of Eastern Ontario (CHEO), Ottawa, ON, Canada

    Background/Purpose: Problems with cognitive functioning are common in childhood-onset systemic lupus erythematosus (cSLE); these may be attributed to many factors including underlying brain inflammation. Socioenvironmental…
  • Abstract Number: 1229 • ACR Convergence 2023

    Longitudinal Assessment of Self-reported Executive Function in Youth with Childhood-Onset Lupus

    Tala El Tal1, justine ledochowski2, Sarah Mossad3, Victoria Lishak3, Ibrahim Mohamed4, Joanna Law3, Lawrence Ng3, Paris Moaf3, Asha Jeyanathan3, Adrienne Davis3, Linda Hiraki3, Deborah Levy3, Zahi Touma5, Natoshia Cunningham6, Ashley Danguecan3 and Andrea Knight3, 1Division of Rheumatology, The Hospital for Sick Children, andDivision of Rheumatology, Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada, 2Department of Psychology, The Hospital for Sick Children, Toronto, ON, Canada, 3The Hospital for Sick Children, Toronto, ON, Canada, 4The Hospital for Sick Children, Brampton, ON, Canada, 5University of Toronto, Toronto, ON, Canada, 6Michigan State University, Grand Rapids, MI

    Background/Purpose: Cognitive dysfunction (including executive dysfunction) affects up to 60% of youth with childhood-onset systemic lupus erythematosus (cSLE), with potential adverse effects on health-related quality…
  • Abstract Number: 1241 • ACR Convergence 2023

    Adverse Childhood Experiences in a Paediatric Systemic Lupus Erythematosus Cohort

    Stephanie Fevrier1, Olivia Hendrikx1, Ashley Danguecan1, Asha Jeyanathan1, Lawrence Ng1, Ibrahim Mohamed2, Paris Moaf1, Sondos Ayyash1, Chelsea DeCoste3, Deborah Levy1, Linda Hiraki1 and Andrea Knight1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital for Sick Children, Brampton, ON, Canada, 3IWK Health Centre, Halifax, NS, Canada

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multiorgan autoimmune disease in which 20% of cases are diagnosed in childhood. Adverse childhood experiences (ACEs) are…
  • Abstract Number: 1242 • ACR Convergence 2023

    Agreement Between Parent- and Self-Report of Executive Function in Adolescents with Childhood-Onset Systemic Lupus Erythematosus

    justine ledochowski1, Sarah Mossad2, Tala El Tal3, Victoria Lishak2, Ibrahim Mohamed4, Joanna Law2, Lawrence Ng2, Paris Moaf2, Asha Jeyanathan2, Adrienne Davis2, Linda Hiraki2, Deborah Levy2, Ashley Danguecan2 and Andrea Knight2, 1Department of Psychology, The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, ON, Canada, 3Children's Hospital of Eastern Ontario (CHEO), Ottawa, ON, Canada, 4The Hospital for Sick Children, Brampton, ON, Canada

    Background/Purpose: Executive functions (EFs) are a set of cognitive skills that enable successful problem solving and goal-directed behavior. EFs are predictive of academic success, mental…
  • Abstract Number: 1456 • ACR Convergence 2023

    Systematic Review of Effects of Systemic Lupus Erythematosus on Brain Structure and Structural Connectivity and Its Relationship with Cognitive Dysfunction Through an Advanced Neuroimaging Lens

    Ibrahim Mohamed1, Tala El Tal2, santiago arciniegas3, Stephanie Fevrier4, justine ledochowski5 and Andrea Knight4, 1The Hospital for Sick Children, Brampton, ON, Canada, 2Children's Hospital of Eastern Ontario (CHEO), Ottawa, ON, Canada, 3University of Toronto, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada, 5Department of Psychology, The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Cognitive dysfunction (CD) is highly prevalent in systemic lupus erythematosus (SLE), and advanced structural magnetic resonance imaging (MRI) has revealed brain abnormalities in patients…
  • Abstract Number: 1461 • ACR Convergence 2023

    Association of Serum Analytes with SLE Cognitive Impairment Phenotypes Formed by Machine Learning: MMP-9, S100A8/A9, IL-6, IL-10, and NGAL

    Michelle Barraclough1, Carolina Munoz-Grajales2, Lauren Erdman3, Juan Pablo Diaz Martinez4, Kathleen Bingham1, Mahta Kakvan5, Roberta Kretzmann6, Carmela Tartaglia7, Lesley Ruttan8, May Choi9, Simone Appenzeller10, Sherief Marzouk6, Dennisse Bonilla4, Patti Katz11, Dorcas Beaton12, Anna Goldenberg13, Robin Green6, Joan Wither1 and Zahi Touma6, 1University Health Network, Toronto, ON, Canada, 2UHN/TWH, Toronto, ON, Canada, 3Hospital for SickKids, Toronto, Toronto, ON, Canada, 4Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 5University Health Network, University of Toronto, Toronto, ON, Canada, 6University of Toronto, Toronto, ON, Canada, 7Krembil Brain Institute, University Health Network, University of Toronto, Toronto, ON, Canada, 8University Health Network, Toronto Rehabilitation Institute, Toronto, ON, Canada, 9University of Calgary, Calgary, AB, Canada, 10UNICAMP, Campinas, Brazil, 11University of California San Francisco, San Rafael, CA, 12Institute for Work & Health, Toronto, ON, Canada, 13Hospital for SickKids, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Cognitive impairment (CI) is highly prevalent in patients with SLE [prevalence of 38% (range: 20%-80%)]. The exact mechanisms underlying CI is complex and multifactorial.…
  • Abstract Number: 1463 • ACR Convergence 2023

    Predictors of Cognitive Impairment in Individuals with Systemic Lupus Erythematosus

    Alexandra Lee1, Sharon Phillips2 and Leslie Crofford3, 1Meharry Medical College, Nashville, TN, 2Vanderbilt University Medical Center, Nashville, TN, 3Vanderbilt University Medical Center, Melbourne, AR

    Background/Purpose: The purpose of this study was to investigate factors associated with objective cognitive impairment in patients diagnosed with Systemic Lupus Erythematous (SLE). Subjective complaints…
  • Abstract Number: 1628 • ACR Convergence 2023

    The Impact of Cardiovascular and Cerebrovascular Disease on the Risk of Dementia in Rheumatoid Arthritis. a Mediation Analysis

    Edward Lovering1, Chanakya Kodishala2, Rakesh Kumar1, Cynthia Crowson1, Ryan Lennon1, John Davis1 and Elena Myasoedova1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic Rochester Minnesota, Rochester, MN

    Background/Purpose: Alzheimer's disease and related dementias have an immense disease burden, with predicted continuous increase in incidence and prevalence. Systemic inflammation plays a major role…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology